Literature DB >> 33316896

UBAC1/KPC2 Regulates TLR3 Signaling in Human Keratinocytes through Functional Interaction with the CARD14/CARMA2sh-TANK Complex.

Pellegrino Mazzone1, Michele Congestrì2, Ivan Scudiero1, Immacolata Polvere2,3, Serena Voccola3, Lucrezia Zerillo3, Gianluca Telesio1, Pasquale Vito2,3, Romania Stilo2, Tiziana Zotti2,3.   

Abstract

CARD14/CARMA2 is a scaffold molecule whose genetic alterations are linked to human inherited inflammatory skin disorders. However, the mechanisms through which CARD14/CARMA2 controls innate immune response and chronic inflammation are not well understood. By means of a yeast two-hybrid screening, we identified the UBA Domain Containing 1 (UBAC1), the non-catalytic subunit of the E3 ubiquitin-protein ligase KPC complex, as an interactor of CARMA2sh, the CARD14/CARMA2 isoform mainly expressed in human keratinocytes. UBAC1 participates in the CARMA2sh/TANK complex and promotes K63-linked ubiquitination of TANK. In human keratinocytes, UBAC1 negatively regulates the NF-κF-activating capacity of CARMA2sh following exposure to poly (I:C), an agonist of Toll-like Receptor 3. Overall, our data indicate that UBAC1 participates in the inflammatory signal transduction pathways involving CARMA2sh.

Entities:  

Keywords:  BCL10; CARD14; CARMA2sh; NF-κB; TANK; UBAC1; Ubiquitin; psoriasis

Mesh:

Substances:

Year:  2020        PMID: 33316896      PMCID: PMC7764236          DOI: 10.3390/ijms21249365

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  35 in total

1.  Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.

Authors:  Hans Häcker; Vanessa Redecke; Blagoy Blagoev; Irina Kratchmarova; Li-Chung Hsu; Gang G Wang; Mark P Kamps; Eyal Raz; Hermann Wagner; Georg Häcker; Matthias Mann; Michael Karin
Journal:  Nature       Date:  2005-11-23       Impact factor: 49.962

2.  CARD14/CARMA2sh and TANK differentially regulate poly(I:C)-induced inflammatory reaction in keratinocytes.

Authors:  Serena Voccola; Immacolata Polvere; Jessica R Madera; Marina Paolucci; Ettore Varricchio; Gianluca Telesio; Piero Porcaro; Pasquale Vito; Romania Stilo; Tiziana Zotti
Journal:  J Cell Physiol       Date:  2019-09-04       Impact factor: 6.384

Review 3.  Ubiquitin chain diversity at a glance.

Authors:  Masato Akutsu; Ivan Dikic; Anja Bremm
Journal:  J Cell Sci       Date:  2016-02-15       Impact factor: 5.285

4.  CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.

Authors:  Mark Mellett; Barbara Meier; Deepa Mohanan; Rebekka Schairer; Phil Cheng; Takashi K Satoh; Betina Kiefer; Caroline Ospelt; Stephan Nobbe; Margot Thome; Emmanuel Contassot; Lars E French
Journal:  J Invest Dermatol       Date:  2018-04-22       Impact factor: 8.551

5.  Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.

Authors:  Mingchao Wang; Shanshan Zhang; Guoxing Zheng; Junjiu Huang; Zhou Songyang; Xueqiang Zhao; Xin Lin
Journal:  Immunity       Date:  2018-07-03       Impact factor: 31.745

6.  Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.

Authors:  Catherine T Jordan; Li Cao; Elisha D O Roberson; Shenghui Duan; Cynthia A Helms; Rajan P Nair; Kristina Callis Duffin; Philip E Stuart; David Goldgar; Genki Hayashi; Emily H Olfson; Bing-Jian Feng; Clive R Pullinger; John P Kane; Carol A Wise; Raphaela Goldbach-Mansky; Michelle A Lowes; Lynette Peddle; Vinod Chandran; Wilson Liao; Proton Rahman; Gerald G Krueger; Dafna Gladman; James T Elder; Alan Menter; Anne M Bowcock
Journal:  Am J Hum Genet       Date:  2012-04-19       Impact factor: 11.025

Review 7.  TLR3: interferon induction by double-stranded RNA including poly(I:C).

Authors:  Misako Matsumoto; Tsukasa Seya
Journal:  Adv Drug Deliv Rev       Date:  2008-01-02       Impact factor: 15.470

8.  MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice.

Authors:  Inna S Afonina; Rudi Beyaert; Elien Van Nuffel; Jens Staal; Griet Baudelet; Mira Haegman; Yasmine Driege; Tino Hochepied
Journal:  EMBO Rep       Date:  2020-04-28       Impact factor: 8.807

9.  The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-κB activation.

Authors:  Egildo Luca D'Andrea; Angela Ferravante; Ivan Scudiero; Tiziana Zotti; Carla Reale; Maddalena Pizzulo; Luigi Regenburgh De La Motte; Chiara De Maio; Pellegrino Mazzone; Gianluca Telesio; Pasquale Vito; Romania Stilo
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

10.  The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling.

Authors:  Gianluca Telesio; Ivan Scudiero; Maddalena Pizzulo; Pellegrino Mazzone; Tiziana Zotti; Serena Voccola; Immacolata Polvere; Pasquale Vito; Romania Stilo
Journal:  Int J Mol Sci       Date:  2017-12-01       Impact factor: 5.923

View more
  4 in total

Review 1.  The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology.

Authors:  Arturo Orlacchio; Pellegrino Mazzone
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

Review 2.  The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway.

Authors:  Elena Campione; Sara Mazzilli; Monia Di Prete; Annunziata Dattola; Terenzio Cosio; Daniele Lettieri Barbato; Gaetana Costanza; Caterina Lanna; Valeria Manfreda; Ruslana Gaeta Schumak; Francesca Prignano; Filadelfo Coniglione; Fabrizio Ciprani; Katia Aquilano; Luca Bianchi
Journal:  Front Med (Lausanne)       Date:  2022-02-08

3.  Panels of mRNAs and miRNAs for decoding molecular mechanisms of Renal Cell Carcinoma (RCC) subtypes utilizing Artificial Intelligence approaches.

Authors:  Seyed Mahdi Hosseiniyan Khatibi; Mohammadreza Ardalan; Mohammad Teshnehlab; Sepideh Zununi Vahed; Saeed Pirmoradi
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

4.  Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated.

Authors:  Naoko Kanda
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.